首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

經導管栓塞和閉塞裝置市場規模、佔有率和成長分析（按類型、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902460

經導管栓塞和閉塞裝置市場規模、佔有率和成長分析（按類型、應用、最終用途和地區分類）－2026-2033年產業預測

Transcatheter Embolization and Occlusion Devices Market Size, Share, and Growth Analysis, By Type (Coil, And Non-coil), By Application (Neurology, Oncology), By End-use, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，經導管栓塞和閉塞裝置市場規模將達到 51.7 億美元，到 2025 年將達到 55.4 億美元，到 2033 年將達到 96.7 億美元，預測期（2026-2033 年）的複合年成長率為 7.2%。

經導管栓塞和閉塞器械的全球市場持續發展，這主要得益於人口老化、有利的報銷政策以及保險覆蓋範圍的擴大等因素，這些因素正推動醫療機構採用相關技術。儘管監管挑戰和競爭構成一定障礙，但該市場仍蘊藏著巨大的成長機遇，尤其是在應對多種疾病方面。亞太和非洲等新興地區為製造商提供了尚未開發的市場潛力，這得益於器械設計和診斷成像技術的創新。醫療專業人員、製造商和研究機構之間的合作將推動技術進步和市場擴張。此外，向患者和醫療機構普及微創治療的益處至關重要，因為人工智慧 (AI) 和數據分析的應用可以提高醫療管理的精準性和個人化程度，從而進一步刺激市場需求。

推動經導管栓塞和閉塞裝置市場發展的因素

癌症、肝病和心血管疾病等慢性疾病的日益流行，推動了對微創醫療干預（例如經導管栓塞和閉塞術 (TEO)）的需求。這些裝置在治療癌症方面特別有效，癌症是全球主要的死亡原因之一，尤其適用於難治性腫瘤。隨著栓塞療法日益被認可為有效的安寧療護選擇，醫療機構擴大採用 TEO 裝置來改善病患預後。醫療機構對 TEO 裝置的日益普及，顯著推動了經導管栓塞和閉塞裝置的市場成長。

經導管栓塞及閉塞裝置市場的限制因素

血液透析技術及相關設備的高昂成本嚴重阻礙了經導管栓塞和封堵裝置的廣泛應用，尤其是在發展中地區。諸如藥物釋放型微球和放射性栓塞試劑盒等先進裝置，其價格本身就容易上漲，這使得小規模醫療機構和經濟困難的患者難以負擔。這種價格敏感性限制了這些產品在新興市場的滲透，並阻礙了它們在資源匱乏地區的普及和使用，最終影響患者獲得這些重要醫療干預的機會。

經導管栓塞和閉塞裝置的市場趨勢

經導管栓塞和閉塞裝置市場正經歷著向非手術治療方案的顯著轉變，這主要得益於患者和醫療服務提供者對微創手術的偏好。這一趨勢凸顯了人們對這些技術優勢的日益認可，包括更少的併發症、更快的恢復時間和更低的手術風險。隨著醫療保健向以患者為中心的模式發展，植入式裝置作為傳統開放性手術的可行替代方案的需求日益成長。這種轉變不僅改善了治療效果，也符合更廣泛的醫療目標，使經導管栓塞和閉塞裝置成為現代治療策略的核心組成部分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Boston Scientific Corporation（US）
Terumo Corporation（Japan）
Medtronic（Ireland）
Abbott（US）
Cook Medical Inc.（US）
Penumbra, Inc.（US）
Cerenovus（a subsidiary of Johnson & Johnson）（US）
Guerbet SA（France）
Merit Medical Systems, Inc.（US）
AngioDynamics, Inc.（US）
B. Braun Melsungen AG（Germany）
Humares（Germany）
Inari Medical, Inc.（US）
MicroVention, Inc.（US）
Endospan Ltd.（Israel）
Teleflex Incorporated（US）
Kaneka Corporation（Japan）
Abbott Vascular（a division of Abbott Laboratories）（US）
SentreHEART, Inc.（US）
Vascular Technologies（US）

簡介目錄

Product Code: SQMIG35A2295

Transcatheter Embolization and Occlusion Devices Market size was valued at USD 5.17 Billion in 2024 and is poised to grow from USD 5.54 Billion in 2025 to USD 9.67 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global market for transcatheter embolization and occlusion devices is evolving, driven by factors such as an aging population, favorable reimbursement policies, and growing insurance coverage, which enhance healthcare providers' adoption of these technologies. While regulatory challenges and competition pose hurdles, the market offers significant growth opportunities, particularly in addressing a diverse range of medical conditions. Emerging regions like Asia-Pacific and Africa present untapped potential for manufacturers, amplified by technological innovations in device design and imaging techniques. Collaborations among healthcare professionals, manufacturers, and research institutions foster advancements and market expansion. Furthermore, educating patients and healthcare providers on the advantages of minimally invasive treatments is crucial, as leveraging artificial intelligence and data analytics can enhance precision and personalization in medical management, driving further demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transcatheter Embolization and Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transcatheter Embolization and Occlusion Devices Market Segments Analysis

Global Transcatheter Embolization and Occlusion Devices Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Coil, and Non-Coil. Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Transcatheter Embolization and Occlusion Devices Market

The rising prevalence of chronic illnesses, including cancer, liver disease, and cardiovascular disorders, is propelling the need for minimally invasive medical interventions like transcatheter embolization and occlusion (TEO) devices. These devices are particularly valuable in addressing cancer, which remains a major cause of mortality globally, especially in the case of hard-to-treat tumors. Embolization methods have gained recognition as effective palliative care options, prompting healthcare providers to incorporate TEO devices to enhance patient outcomes. This increasing adoption within medical facilities is significantly driving the growth of the transcatheter embolization and occlusion devices market.

Restraints in the Transcatheter Embolization and Occlusion Devices Market

The high costs associated with hemodialysis techniques and related equipment present a significant obstacle to the broader adoption of Transcatheter Embolization and Occlusion Devices, particularly in developing areas. The advanced nature of devices like drug-elution beads and radio-embolization kits contributes to their elevated prices, which can render them unaffordable for smaller healthcare providers and financially disadvantaged patients. This sensitivity to pricing limits the ability of these products to penetrate emerging markets, inhibiting their availability and use in regions where healthcare resources are limited, ultimately affecting patient access to these important medical interventions.

Market Trends of the Transcatheter Embolization and Occlusion Devices Market

The Transcatheter Embolization and Occlusion Devices market is witnessing a significant shift towards nonsurgical treatment options, driven by both patient and provider preferences for minimally invasive procedures. This trend highlights a growing recognition of the benefits associated with such techniques, including reduced complications, quicker recovery periods, and diminished surgical risks. As healthcare moves increasingly towards patient-centered care, the demand for implantable devices as viable alternatives to traditional open surgery is escalating. This shift not only enhances therapeutic outcomes but also aligns with broader healthcare goals, positioning TEO devices as pivotal components in contemporary treatment strategies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Patent Analysis
Regulatory Landscape
Top Investment Analysis
Key Success Factor
Degree of Competition

Transcatheter Embolization and Occlusion Devices Market byType

Market Overview
Coil
- Pushable Coils
- Detachable Coils
Non-Coil
- Flow Diverting Devices
- Embolization Particles
- Liquid Embolics
- Others

Transcatheter Embolization and Occlusion Devices Market byApplication

Market Overview
Peripheral Vascular Disease
- Arterial Blockage
- Venous Blood clot
- Others
Oncology
Neurology
- Brain Aneurysm
- Cerebral Arteriovenous Malformations
- Others
Urology
- Benign Prostatic Hyperplasia/Urinary Retention
- Others
- Varicocele
Others

Transcatheter Embolization and Occlusion Devices Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerenovus (a subsidiary of Johnson & Johnson) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Humares (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endospan Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Vascular (a division of Abbott Laboratories) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SentreHEART, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments